Profusa (PFSA) Deferred Taxes (2023 - 2024)
Profusa's (PFSA) quarterly Deferred Taxes came in at $13661.0 in Q1 2024, up 138.38% year-on-year from $5730.8 in Q2 2023, and up 200.0% quarter-over-quarter from -$13661.0 in Q4 2023.
Profusa (PFSA) Deferred Taxes (2023 - 2024) Analysis & Trends
Profusa's Deferred Taxes history runs 2 years deep, the most recent figure standing at $13661.0 for Q1 2024.
- On a quarterly basis, Deferred Taxes rose 138.38% year-over-year to $13661.0 in Q1 2024; TTM through Dec 2024 was $13661.0, a 41.32% decrease from a year earlier, with the FY2024 full-year figure at $13661.0, down 41.32% from the prior year.
- Deferred Taxes grew to $13661.0 in Q1 2024 per PFSA's latest filing, from -$13661.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $72537.0 in Q2 2023 and bottomed at -$35597.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -33.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -8.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -9.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 7.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 51.51 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Profusa | 23,566.40 | -351,433.60 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 13,661.00 |
| Dec 31, 2023 | -13,661.00 |
| Jun 30, 2023 | 72,537.00 |
| Mar 31, 2023 | -35,597.00 |